Thrombotic Thrombocytopenic Purpura (TTP): From Discovery of ADAMTS13 to Practice Guidelines
Thrombotic Thrombocytopenic Purpura (TTP) From Discovery of ADAMTS13 to Practice Guidelines Presented by Long Zheng, M.D., Ph.D Department of Pathology & Laboratory Medicine University of Kansas Medical Center August 10, 2020
▶︎
Advances in iTTP Research
▶︎
Clinical Updates on Thrombotic Thrombocytopenic Purpura (TTP)
▶︎
Heparin-Induced Thrombocytopenia (HIT) Explained | Pathology, 4T Score, Diagnosis & Management
▶︎
AAMAC Toronto Education Day 2026 (MDS and Aplastic Anemia)
▶︎
NIFA BARD IIA Food and Nutrition Innovation Showcase 2026 Part 4 Dr Hagai Shpigler
▶︎
Topic on Focus on Thrombotic Microangiopathies: ADAMTS13-related TTP pathophysiology
▶︎
Bioinformatic Approach for Drug Discovery FKUH
▶︎
USTMA Patient Meeting: Preventing Relapse
▶︎
2026 June Accelerating the Discovery and Development of GLP-1 Based Therapeutics with MID3
▶︎
2026 GRAPPA Virtual Congress Highlights EULAR
▶︎
Signs & Symptoms of Myasthenia Gravis - Part 1
▶︎
Heart Failure with Timothy Fendler, MD | What You Need to Know
▶︎
SSBMT Webinar Series - How I Treat Thrombotic Thrombocytopenic Purpura (TTP) - 21 November
▶︎
Advancements in TTP: Newest treatments in cTTP and iTTP
▶︎
Leukemias: Pathology review
▶︎
2026 CDG Miniseries | Gene Editing in Rare Diseases | Dr. Rebecca Ahrens-Nicklas | Episode TEN
▶︎
Diagnosis of TTP
▶︎
AAMAC Toronto Education Day 2026 (PNH)
▶︎
Congenital Syphilis:Prevention through screening and treatment. Joan Duggan, MD, MPH,FIDSA, AAHIVM
▶︎